Altrinsic Global Advisors’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-70,286
| Closed | -$1.19M | – | 85 |
|
|
2019
Q4 | $1.19M | Sell |
70,286
-50,000
| -42% | -$847K | 0.05% | 64 |
|
|
2019
Q3 | $1.85M | Hold |
120,286
| – | – | 0.08% | 54 |
|
|
2019
Q2 | $2.82M | Buy |
120,286
+70,000
| +139% | +$1.64M | 0.13% | 51 |
|
|
2019
Q1 | $1.43M | Sell |
50,286
-25,000
| -33% | -$708K | 0.07% | 67 |
|
|
2018
Q4 | $2.27M | Sell |
75,286
-20,000
| -21% | -$603K | 0.11% | 54 |
|
|
2018
Q3 | $3.34M | Sell |
95,286
-102,514
| -52% | -$3.59M | 0.15% | 52 |
|
|
2018
Q2 | $4.69M | Buy |
197,800
+10,000
| +5% | +$237K | 0.19% | 49 |
|
|
2018
Q1 | $4.81M | Buy |
187,800
+37,800
| +25% | +$968K | 0.19% | 47 |
|
|
2017
Q4 | $2.6M | Buy |
150,000
+25,000
| +20% | +$434K | 0.1% | 60 |
|
|
2017
Q3 | $3.46M | Buy |
+125,000
| New | +$3.46M | 0.13% | 60 |
|